Since 2014, the first studies conducted on BM samples from CML patients confirmed the presence of CML-specific CD34+ CD38− CD26+ LSCs, while CD26+ LSCs were not detected in BM of normal subjects and BM of patients affected by other hematological diseases. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.